Hudson Introduces Bipartisan Legislation to Increase Access to Plasma-Based Medicines

“The Alpha-1 Foundation is proud to endorse The PLASMA Act in support of patients with rare diseases, like Alpha-1 antitrypsin deficiency and […]

Read More… from Hudson Introduces Bipartisan Legislation to Increase Access to Plasma-Based Medicines

Alpha-1 Foundation partners with rare disease organizations to applaud the introduction of a bill to improve access to evidence-based care for rare disease patients

The Alpha-1 Foundation, along with 60 rare disease organizations, is proud to support the “PROTECT Rare Act” to support patients […]

Read More… from Alpha-1 Foundation partners with rare disease organizations to applaud the introduction of a bill to improve access to evidence-based care for rare disease patients

Fraughen Blue Paper Published in the latest issue of the American Journal of Respiratory and Critical Care Medicine

Augmentation Therapy For Severe Alpha-1 Antitrypsin Deficiency Improves Survival And Is Decoupled From Spirometric Decline- A Multi-National Registry Analysis Authors: […]

Read More… from Fraughen Blue Paper Published in the latest issue of the American Journal of Respiratory and Critical Care Medicine